New risk assessment tool developed for predicting outcomes in heart failure patients

FHS
May 14, 2024
8:30 pm

UVA Health researchers have developed a powerful new risk assessment tool for predicting outcomes in heart failure patients. The researchers have made the tool publicly available for free to clinicians.

The Many Use Cases for Psilocybin-Assisted Therapy | Psychedelic Invest

Psilocybin, a key compound in several species of hallucinogenic mushrooms, is at the forefront of the psychedelic renaissance. It has shown promise in treating various

July 25, 2024

SEC charges former Pfizer statistician with insider trading over Paxlovid clinical trial results

A former Pfizer statistician on Thursday was charged by U.S. authorities with insider trading for acting on advance information about trial results for the Paxlovid

June 29, 2023

Natural Medicine Advisory Bulletin #4: September 2023 – Psychedelic Alpha

*** One new non-voting participant was introduced in the September meeting of the Qualifications, Licensing, and Training subcommittee. The new participant, Luke Priel, is a

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.